225 related articles for article (PubMed ID: 14694087)
1. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.
Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO
J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989
[TBL] [Abstract][Full Text] [Related]
3. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.
Yang OO; Sarkis PT; Trocha A; Kalams SA; Johnson RP; Walker BD
J Immunol; 2003 Oct; 171(7):3718-24. PubMed ID: 14500671
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
5. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
[TBL] [Abstract][Full Text] [Related]
6. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
7. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
Ali A; Ng HL; Dagarag MD; Yang OO
Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
[TBL] [Abstract][Full Text] [Related]
8. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
Tomiyama H; Akari H; Adachi A; Takiguchi M
J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
[TBL] [Abstract][Full Text] [Related]
9. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
[TBL] [Abstract][Full Text] [Related]
10. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
11. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
12. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
Altfeld MA; Trocha A; Eldridge RL; Rosenberg ES; Phillips MN; Addo MM; Sekaly RP; Kalams SA; Burchett SA; McIntosh K; Walker BD; Goulder PJ
J Virol; 2000 Sep; 74(18):8541-9. PubMed ID: 10954555
[TBL] [Abstract][Full Text] [Related]
13. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations.
Ali A; Pillai S; Ng H; Lubong R; Richman DD; Jamieson BD; Ding Y; McElrath MJ; Guatelli JC; Yang OO
J Immunol; 2003 Oct; 171(8):3999-4005. PubMed ID: 14530319
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
15. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
16. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.
Adnan S; Balamurugan A; Trocha A; Bennett MS; Ng HL; Ali A; Brander C; Yang OO
Blood; 2006 Nov; 108(10):3414-9. PubMed ID: 16882705
[TBL] [Abstract][Full Text] [Related]
17. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.
Yang OO; Nguyen PT; Kalams SA; Dorfman T; Göttlinger HG; Stewart S; Chen IS; Threlkeld S; Walker BD
J Virol; 2002 Feb; 76(4):1626-31. PubMed ID: 11799157
[TBL] [Abstract][Full Text] [Related]
18. Cutting Edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication.
Tomiyama H; Fujiwara M; Oka S; Takiguchi M
J Immunol; 2005 Jan; 174(1):36-40. PubMed ID: 15611225
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.
Mealey RH; Lee JH; Leib SR; Littke MH; McGuire TC
J Immunol; 2006 Nov; 177(10):7377-90. PubMed ID: 17082657
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]